BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Harvard Researchers Uncover Insight into T Cells and Autoimmune Disease

  Researchers from Harvard Medical School have published data in Science Daily involving the role of T cells in autoimmune diseases.

  June 28, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  Kezar Stock Soars on Positive Lupus Nephritis Data

  Kezar Life Sciences stock rose 92% after it announced positive topline results from its Phase II clinical trial investigating the use of zetomipzomib for the treatment of Lupus Nephritis (LN).

  June 28, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  Dr. Pearl Huang Named CEO of Novartis-Backed Dunad Therapeutics (Updated)

  Pearl Huang, Ph.D, has been appointed the CEO of U.K.-based Dunad Therapeutics, a Novartis-backed biopharmaceutical startup.

  June 28, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Business

  Boehringer Expands BiomX IBD Biomarker Collab, Shutters Crohn’s Trial

  Boehringer and BiomX intend to use the discovery platform to identify biomarkers for a pathogenic bacterium thought to be associated with IBD.

  June 28, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Biogen Community Lab 2.0 Reveals Wonders of Science to Thousands of Students

  Biogen’s Chirfi Guindo discusses the launch of the company’s next-generation approach to teaching STEM to even more students, leading to potential careers in the field.

  June 28, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Roivant Reduces Pipeline by Several Programs Across Vants

  Roivant Sciences announced it has discontinued development of several assets following a pipeline reprioritization.

  June 28, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Novartis Reveals Restructure will Cost up to 8,000 Jobs

  Swiss biopharma giant Novartis plans to cut up to 8,000 jobs in hopes of saving at least $1 billion by 2024.

  June 28, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Spero Searching for Way Forward after FDA Rejects cUTI Drug

  Spero Therapeutics received a Complete Response Letter from the U.S. Food and Drug Administration for its complicated urinary tract infection therapy, tebipenem HBr oral tablets.

  June 28, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Eiger’s HDV Program Sees Cirrhosis in Younger Patients (Updated)

  The findings, presented during a poster session at the EASL 2022 International Liver Congress, revealed that of the 407 D-LIVR participants, nearly 30% developed liver cirrhosis.

  June 28, 2022

   · 

  3 min read

   · 

  Tristan Manalac
• 

  Drug Development

  New Study: COVID-19 May Cause or Accelerate Neurological Diseases

  Danish researchers published a study suggesting that COVID-19 increases the risk of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.

  June 28, 2022

   · 

  3 min read

   · 

  Mark Terry